Lumiera Health Inc
XTSX:NHP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its Industry Average (4.3), the stock would be worth CA$0 (100% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | CA$0.01 |
0%
|
| Industry Average | 4.3 | CA$0 |
-100%
|
| Country Average | 2.7 | CA$0 |
-100%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Lumiera Health Inc
XTSX:NHP
|
849.9k CAD | 0 | -0.2 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
308.8B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 1 319.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
101.6B ZAR | 1.1 | 10.5 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.1B USD | 1 961.7 | 38 458.7 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
55.3B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
38.1B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
32.4B EUR | 7.8 | 174.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.8B USD | 54.3 | -3 318.9 | |
| US |
Q
|
Qnity Electronics Inc
NYSE:Q
|
30.3B USD | 0 | 0 |
Market Distribution
Other Multiples
Lumiera Health Inc
Glance View
Lumiera Health, Inc. engages in the commercialization and development of evidence-based botanical products for the healthcare and bio-agriculture. The company is headquartered in Montreal, Quebec. The company went IPO on 2013-11-14. The firm is focused on selling natural products as well as the development and commercialization of botanical-based products for human health care. The firm also operates as product development, marketing and sales business of natural products. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The firm is also providing solutions for chronic pain and inflammation. The company is also helping people to improve health by delivering products. The Company’s subsidiary is Holizen Laboratory Inc.
